Results 41 to 50 of about 38,609 (257)

A Meta-Analysis of Extended-Interval Dosing Versus Multiple Daily Dosing of Aminoglycosides [PDF]

open access: yesClinical Infectious Diseases, 1997
We conducted a meta-analysis of 22 randomized, controlled trials in which extended-interval dosing of aminoglycosides was compared with multiple daily dosing. When we classified intermediate outcomes as successes, we found that patients receiving extended-interval dosing were at significantly reduced risk of clinical treatment failure (risk difference,
T C, Bailey   +4 more
openaire   +2 more sources

Healthcare resource utilization and costs for extended interval dosing of natalizumab in multiple sclerosis

open access: yes, 2022
Aims: Natalizumab is approved as an infusion every 4 weeks (standard-interval dosing [SID]) in relapsing-remitting multiple sclerosis (MS). Extended-interval dosing (EID) reduces risk of progressive multifocal leukoencephalopathy (PML) compared with SID,
Lanzillo, Roberta   +9 more
core   +1 more source

Effectiveness of lanreotide autogel 120 mg at extended dosing intervals for acromegaly [PDF]

open access: yesEndocrine, 2020
Abstract Purpose Recent data indicate that extended dosing intervals (EDIs) with lanreotide autogel 120 mg are effective and well-received among patients with acromegaly who have achieved biochemical control with monthly injections of long-acting somatostatin analogues (SSAs).
Ignacio Bernabéu   +12 more
openaire   +9 more sources

Immunogenicity of Alternative Dosing Schedules for HPV Vaccines among Adolescent Girls and Young Women: A Systematic Review and Meta-Analysis

open access: yesVaccines, 2020
Alternative dosing schedules for licensed human papilloma virus (HPV) vaccines, particularly single dose and extended intervals between doses (>12 months), are being considered to address vaccine shortages and improve operational flexibility. We searched
Andrew M. Secor   +8 more
doaj   +1 more source

Flexibility of oral cholera vaccine dosing-a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2015
BACKGROUND:A bivalent killed whole cell oral cholera vaccine has been found to be safe and efficacious for five years in the cholera endemic setting of Kolkata, India, when given in a two dose schedule, two weeks apart.
Suman Kanungo   +16 more
doaj   +1 more source

The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial

open access: yesInternational Journal of Infectious Diseases, 2023
Objectives: To evaluate the immunogenicity of an extended interval regimen of BNT162b2 among healthy school-age children. Methods: A randomized-control trial conducted among healthy Thai children aged 5-11 years.
Napaporn Chantasrisawad   +8 more
doaj   +1 more source

Covid-19 vaccination: What’s the evidence for extending the dosing interval?

open access: yesBMJ, 2021
On 30 December the four UK chief medical officers announced that the second doses of the covid vaccines should be given towards the end of 12 weeks rather than in the previously recommended 3-4 weeks.
Iacobucci, Gareth, Mahase, Elisabeth
openaire   +2 more sources

Time Toxicity in Wilms Tumor: Quantifying the Burden of Healthcare Interaction in the First Year After Diagnosis

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Wilms tumor (WT) treatment imposes a significant time burden on patients and their families. Time toxicity is a patient‐centered metric that quantifies the burden of healthcare interaction. We sought to define time toxicity in the first year after diagnosis of WT and hypothesized that it would increase as tumor stage and treatment ...
Caleb Q. Ashbrook   +6 more
wiley   +1 more source

Time-dependent pharmacodynamics of amikacin on Mycobacterium abscessus growth and resistance emergence

open access: yesMicrobiology Spectrum
Mycobacterium abscessus pulmonary disease is increasing in prevalence globally, particularly for individuals with cystic fibrosis. These infections are challenging to treat due to a high rate of resistance.
Joy E. Gibson   +2 more
doaj   +1 more source

From injection therapies to natalizumab: views on the treatment of multiple sclerosis

open access: yesTherapeutic Advances in Neurological Disorders, 2012
Discoveries of the mechanisms that underlie the pathogenesis of multiple sclerosis have been acquired at an impressive rate over the last few decades and, as a consequence, a growing number of treatments are becoming available for this disease.
Roberto Bomprezzi   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy